                               SEQUENCE LISTING

<110> THE UNIVERSITY OF TOLEDO
 
<120> XENOANTIGEN-DISPLAYING ANTI-CANCER VACCINES AND METHOD OF MAKING

<130> 1-53665/D2012-14

<140>
<141>

<150> 61/599,925
<151> 2012-02-16

<160> 15 

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Alpha-GalNAc-O-Thr(Tn) TACA

<400> 1
Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro Ala His Gly 
1               5                   10                  15      


Val Thr Ser Ala 
            20  


<210> 2
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Dipalmitoyl-S-glyceryl-Cys

<400> 2
Cys Ser Lys Lys Lys Lys 
1               5       


<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Tripalmitoyl-S-glyceryl-Cys

<400> 3
Cys Ser Lys Lys Lys Lys 
1               5       


<210> 4
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Dipalmitoyl-S-glyceryl-Cys

<400> 4
Cys Gly Asn Asn Asp Glu Ser Asn Ile Ser Phe Lys Glu Lys 
1               5                   10                  


<210> 5
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro 
1               5                   10                  15      


Ala His Gly Val 
            20  


<210> 6
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (6)..(6)
<223> Alpha-GalNAc-O-Thr(Tn) TACA

<400> 6
Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro 
1               5                   10                  15      


Ala His Gly Val 
            20  


<210> 7
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Tripalmitoyl-S-glyceryl-Cys

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Alpha-GalNAc-O-Thr(Tn) TACA
 
<400> 7
Cys Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro Ala His 
1               5                   10                  15      


Gly Val Thr Ser Ala 
            20      


<210> 8
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 5-azido hexanoic acid

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Thr(Ac3alpha-GalNAc)

<400> 8
Xaa Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro Ala His 
1               5                   10                  15      


Gly Val Thr Ser Ala 
            20      


<210> 9
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 5-azido hexanoic acid

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Thr(Ac3alpha-GalNAc) or alpha-GalNAc-O-Thr(Tn) TACA

<400> 9
Xaa Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro Ala His 
1               5                   10                  15      


Gly Val Thr Ser Ala 
            20      


<210> 10
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 5-azido hexanoic acid

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Alpha-GalNAc-O-Thr(Tn) TACA

<400> 10
Xaa Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro Ala His 
1               5                   10                  15      


Gly Val Thr Ser Ala 
            20      


<210> 11
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 5-azido hexanoic acid

<400> 11
Xaa Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro 
1               5                   10                  15      


Pro Ala His Gly Val 
            20      


<210> 12
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Tripalmitoyl-S-glyceryl-Cys

<400> 12
Cys Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro 
1               5                   10                  15      


Pro Ala His Gly Val 
            20      


<210> 13
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 5-azido hexanoic acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Thr(Ac3alpha-GalNAc)

<400> 13
Xaa Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro 
1               5                   10                  15      


Pro Ala His Gly Val 
            20      


<210> 14
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 5-azido hexanoic acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Thr(Ac3alpha-GalNAc) or alpha-GalNAc-O-Thr(Tn) TACA

<400> 14
Xaa Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro 
1               5                   10                  15      


Pro Ala His Gly Val 
            20      


<210> 15
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Tripalmitoyl-S-glyceryl-Cys

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Alpha-GalNAc-O-Thr(Tn) TACA

<400> 15
Cys Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro 
1               5                   10                  15      


Pro Ala His Gly Val 
            20      


